This Is Too Hot For Doximity Inc (NYSE: DOCS), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that Doximity Ranked #1 Best in KLAS Telehealth Video Conferencing Platform for Third Consecutive Year.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

As a NYSE listed company, DOCS falls under the Healthcare sector while operating within the Health Information Services industry segment. The current market capitalization of Doximity Inc is $5.22B. A total of 7.1 million shares were traded on the day, compared to an average of 3.61 shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, DOCS has seen 2 BUY and 4 SELL insider trades, representing the acquisition of 2,892,000 and the disposition of 2,895,271 shares. Over the last 12 months, there were 20 BUYs and 20 SELLs from insiders. Insiders purchased 10,352,716 shares during that period but sold 10,187,787.

In the most recent transaction, Wampler Kira Scherer sold 2,500 shares of DOCS for 27.05 per share on Feb 01. After the transaction, the Director now owns 10,258 company shares. In a previous transaction on Jan 02, Wampler Kira Scherer sold 5,000 shares at 28.27 per share. DOCS shares that Director owns now total 10,258.

Among the insiders who sold shares, Wampler Kira Scherer disposed of 2,500 shares on Dec 15 at a per-share price of $26.65. This resulted in the Director holding 10,258 shares of DOCS after the transaction. In another insider transaction, Wampler Kira Scherer sold 2,500 shares at $26.00 per share on Dec 14. Company shares held by the Director now total 10,258.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for DOCS in the last 3 months, the mean price target is $28.31 with high estimates of $34.00 and low estimates of $22.00. In terms of 52-week highs and lows, DOCS has a high of $38.10 and a low of $19.71.

As of this writing, DOCS has an earnings estimate of $0.2 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $0.24 per share and a lower estimate of $0.13. The company reported an EPS of $0.22 in the last quarter, which was 22.20% higher than expectations of $0.18.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DOCS’s latest balance sheet shows that the firm has $798.11M in Cash & Short Term Investments as of fiscal 2022. There were $1.09M in debt and $111.28M in liabilities at the time. Its Book Value Per Share was $4.64, while its Total Shareholder’s Equity was $878.59M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DOCS is Buy with a score of 3.19.

Most Popular

Related Posts